Prohibix, LLC
Hydrogel microparticles that sustain intra-articular release of high molecular weight hyaluronic acid for knee osteoarthritis treatment
- Sector
- Medtech
- Headquarters
- Philadelphia, PA
- Total capital
- $3.7M
- Federal grants
- $3.7M
- 6 awards · 2018–2021
- Rank in peer group#18 of 36
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 11 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Redesigning the Viscosupplement to Enhance the Mechanical and Biological Actions of Hyaluronic Acid$250K
- Federal grantHealth and Human S · Phase II · Myocardial Delivery of MMP Inhibiting Hydrogels$101K
- Federal grantHealth and Human S · Phase II · Myocardial Delivery of MMP Inhibiting Hydrogels$995K
- Federal grantHealth and Human S · Phase II · Myocardial Delivery of MMP Inhibiting Hydrogels$27K
- Federal grantHealth and Human S · Phase II · Myocardial Delivery of MMP Inhibiting Hydrogels$2.1M
- Federal grantHealth and Human S · Phase I · Myocardial delivery of MMP inhibiting hydrogels$246K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 36 peers
Line = medianMedtech · Material
- Federal grants#18 · top 50%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 11- PendingBulking And Collagen Stimulating Hydrogel CompositionsUSPTOApplication 18701151
- PendingCrosslinked Hyaluronic Acid PrecipitatesUSPTOApplication 18701138
- PendingControlled Release Hyaluronic Acid CompositionsUSPTOApplication 17919410
Show all 11 patent records
- Bulking And Collagen Stimulating Hydrogel CompositionsJan 2, 2025 · Application 18701151Pending
- Crosslinked Hyaluronic Acid PrecipitatesOct 24, 2024 · Application 18701138Pending
- Controlled Release Hyaluronic Acid CompositionsJun 8, 2023 · Application 17919410Pending
- Bulking And Collagen Stimulating Hydrogel CompositionsApplication PCTUS2022046854Pending
- Crosslinked Hyaluronic Acid PrecipitatesApplication PCTUS2022046831Pending
- Crosslinked Hyaluronic Acid PrecipitatesApplication 63355884Pending
- Bulking And Collagen Stimulating Hydrogel CompositionsApplication 63256112Pending
- Hyaluronic Acid Compositions With Low Extents Of Ester Linkages And Methods Of Use ThereofApplication 19475258Pending
- High Density Hydrolyzing Hyaluronic Acid ParticlesApplication 63256108Pending
- Hyaluronic Acid Compositions With Low Extents Of Ester Linkages And Methods Of Use ThereofApplication PCTUS2024024399Pending
- Hyaluronic Acid Hydrogels With Low Extents Of Acrylate ModificationApplication 63496226Pending
Related companies, and why
- Blaze Medical DevicesSimilar federal contract value in Medtech · null in contracts
- ASSISTIVE TECHNOLOGY DEVELOPMENT, INC.Similar federal contract value in Medtech · null in contracts
- FROM THE FUTURE, LLCSimilar federal contract value in Medtech · null in contracts
- Innovative BioChips LLCSimilar federal contract value in Medtech · null in contracts
- INDUSTRIAL SCIENCE & TECHNOLOGY NETWORK, INC.Similar federal contract value in Medtech · null in contracts
- VITALQUAN, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .